NCT05179629View on ClinicalTrials.gov

M-Tapa Block for Laparoscopic Cholesistectomy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

July 20, 2022

Study Completion Date

August 1, 2022

Conditions
CholecystitisCholecystitis, AcuteCholecystitis, Chronic
Interventions
DRUG

M TAPA block

Under aseptic conditions, a high frequency linear probe will be placed on the costochondral angle in the sagittal plane. Then the probe will be slightly angled deeply to visualize the lower view of the perichondrium. We will perform M-TAPA with totally 30 ml (15 ml for each side) of %0,25 bupivacaine.

Trial Locations (1)

34070

Istanbul Medipol University Hospital, Istanbul

All Listed Sponsors
lead

Medipol University

OTHER

NCT05179629 - M-Tapa Block for Laparoscopic Cholesistectomy | Biotech Hunter | Biotech Hunter